Aptus Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE15XJ01010
  • NSEID:
  • BSEID: 544529
INR
487.45
9.55 (2.0%)
BSENSE

Nov 20

BSE+NSE Vol: 8400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.4 k (-22.79%) Volume

Shareholding (Sep 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

72.89%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 820 Cr (Micro Cap)

stock-summary
P/E

181.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.36

stock-summary
Return on Equity

16.26%

stock-summary
Price to Book

28.84

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
71.07%
0%
71.07%
6 Months
163.49%
0%
163.49%
1 Year
692.6%
0%
692.6%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Aptus Pharma for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Board Meeting Outcome for Outcome Of Board Meeting - Allotment Of Equity Shares On Preferential Basis Under Regulation 30 Of SEBI LODR Regulations 2015

12-Nov-2026 | Source : BSE

Outcome of Board Meeting - Allotment of Equity Shares on Preferential Basis under Regulation 30 of SEBI LODR Regulations 2015

Board Meeting Intimation for Intimation Of Board Meeting For Allotment Of Equity Shares On Preferential Basis

06-Nov-2026 | Source : BSE

Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve Intimation of Board Meeting for allotment of Equity Shares on Preferential Basis

Receipt Of In-Principle Approval For Preferential Issue

30-Oct-2026 | Source : BSE

Receipt of In-Principle Approval for Preferential Issue

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Aptus Pharma Ltd has announced 3:2 bonus issue, ex-date: 12 May 26

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
61.50%
EBIT Growth (5y)
129.91%
EBIT to Interest (avg)
4.28
Debt to EBITDA (avg)
1.43
Net Debt to Equity (avg)
0.36
Sales to Capital Employed (avg)
1.17
Tax Ratio
27.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
23.62%
ROE (avg)
19.79%
Valuation key factors
Factor
Value
P/E Ratio
181
Industry P/E
40
Price to Book Value
29.42
EV to EBIT
120.38
EV to EBITDA
113.75
EV to Capital Employed
21.85
EV to Sales
18.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.15%
ROE (Latest)
16.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Tejash Maheshchandra Hathi (11.44%)

Highest Public shareholder

None

Individual Investors Holdings

24.55%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Aptus Pharma"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Aptus Pharma"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Aptus Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Aptus Pharma"
  }
]
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details